UK markets closed

RAPT Therapeutics, Inc. (RAPT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.0400-0.1000 (-2.42%)
At close: 04:00PM EDT
4.0400 0.00 (0.00%)
After hours: 04:03PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-78,816
-116,798
-83,838
-69,204
-52,892
Depreciation & amortisation
1,026
1,216
1,047
996
1,123
Stock-based compensation
10,325
17,091
11,264
9,952
8,686
Change in working capital
-3,901
5,499
-1,335
-4,298
2,344
Accounts payable
1,355
7,335
3,710
933
2,390
Other working capital
-69,793
-98,173
-71,616
-61,781
-40,889
Other non-cash items
2,335
2,335
1,760
-
-
Net cash provided by operating activities
-68,603
-97,048
-70,771
-61,026
-40,491
Cash flows from investing activities
Investments in property, plant and equipment
-1,190
-1,125
-845
-755
-398
Purchases of investments
-129,645
-161,497
-190,856
-164,977
-139,334
Sales/maturities of investments
110,723
266,755
146,211
84,385
52,297
Net cash used for investing activities
-20,112
104,133
-45,490
-81,347
-87,435
Cash flows from financing activities
Common stock issued
54,951
0
129,788
139,460
73,610
Net cash used provided by (used for) financing activities
56,422
1,447
131,180
141,482
75,461
Net change in cash
-32,293
8,532
14,919
-891
-52,465
Cash at beginning of period
59,999
38,946
24,027
24,918
77,383
Cash at end of period
27,706
47,478
38,946
24,027
24,918
Free cash flow
Operating cash flow
-68,603
-97,048
-70,771
-61,026
-40,491
Capital expenditure
-1,190
-1,125
-845
-755
-398
Free cash flow
-69,793
-98,173
-71,616
-61,781
-40,889